Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019 (Front. Public Health., (2021), 9, 667253, 10.3389/fpubh.2021.667253)

Anna Maisa, Christian Kollan, Matthias an der Heiden, Florian van Bömmel, Markus Cornberg, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Sandra Dudareva (Corresponding Author)

Research output: Contribution to journalErratumpeer-review

Abstract

In the original article, there was a mistake in the order of figures for Figures 1–3 as published. Figure 1 should be Figure 3, Figure 2 should be Figure 1, and Figure 3 should be Figure 2. The legends and references in the manuscript for all three figures were correct. The corrected Figures 1–3 appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number860836
JournalFrontiers in Public Health
Volume10
DOIs
Publication statusPublished - 11 Mar 2022
Externally publishedYes

Keywords*

  • hepatitis B
  • hepatitis elimination
  • nucleos(t)ide therapy
  • therapy costs
  • treatment gap
  • treatment guidelines

Field of Science*

  • 3.3 Health sciences

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019 (Front. Public Health., (2021), 9, 667253, 10.3389/fpubh.2021.667253)'. Together they form a unique fingerprint.

Cite this